L-Valine-¹³C₅ - ≥99 atom% 13C,≥97% , CAS No.55443-52-2

CAS: 55443-52-2 Cat. No.: L474033 Formula: (13CH3)213CH13CH(NH2)13COOH Molecular Weight: 122.11
AVAILABLE TO ORDER
GRADE & PURITY ≥99 atom% 13C,≥97%
Storage
Room temperature
★
Size
Germany (EU)
USA*
Price
Qty
100mg
L474033-100mg
Made to order · 8–12 wks

€1,029.92

€1,202.60
Save €172.68 (14.36%)
Enter a quantity for the sizes you want to add.

Specifications

Specifications & Purity
≥99 atom% 13C,≥97%
Storage
Room temperature
Purity
≥99 atom% 13C,≥97%
Names and Identifiers
SMILES
[13CH3][13CH]([13CH3])[13C@H](N)[13C](O)=O
InChIKey
KZSNJWFQEVHDMF-JRGPAWSWSA-N
InChI
1S/C5H11NO2/c1-3(2)4(6)5(7)8/h3-4H,6H2,1-2H3,(H,7,8)/t4-/m0/s1/i1+1,2+1,3+1,4+1,5+1
Molecular Weight
122.11
Reaxys
15776173
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=15776173&ln=

Advanced Data

3D Structure
Interactive Chemical Structure Model





Certificates (CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
x_flash_point_drop_fahrenheitNot applicable
x_flash_point_drop_centigradeNot applicable
x_melt_point_char295-300℃ (lit.)
Safety and Hazards(GHS)
x_reaxy_rn
15776173
x_reaxys_rn_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=15776173&ln=
x_ridadr
NONH for all modes of transport
Solution Calculators
Reviews

Customer Reviews

Application Protocols

No item‑specific validated protocols are provided in the Product Data. The following are general, non‑validated guidelines for common uses; adjust per your instrumentation and experimental design.

  • LC‑MS internal standard for valine:
    • Prepare a 1–10 mM stock in water or 50:50 water:MeOH with 0.1% formic acid. Store aliquots at ≤−20 °C.
    • Spike biofluid samples to a final concentration appropriate for the assay’s dynamic range (e.g., 1–10 µM). Perform protein precipitation with cold acetonitrile (3:1 v/v), centrifuge, and analyze supernatant by LC‑MS/MS.
    • Monitor MRM transitions offset by +5 m/z relative to unlabeled valine; correct for natural abundance as needed.
  • 13C tracer in cell culture:
    • Supplement medium with 13C5‑valine at physiological or designed tracer levels (e.g., 50–400 µM total valine with defined labeled fraction). Filter sterilize solutions (0.22 µm).
    • Sample cells/metabolites at defined time points; quench with cold 80% MeOH; analyze isotopologue distributions in intracellular metabolites and protein hydrolysates.
  • 13C NMR reference:
    • Dissolve ~10–50 mM in D2O; adjust pD with DCl/NaOD; acquire 13C spectra with appropriate relaxation delays for quantitative work.

Always confirm concentration, isotopic enrichment, and matrix compatibility with small‑scale pilots before full experiments.

Biological Roles

Content below reflects general biochemistry of L‑valine; isotopic labeling with 13C does not alter its biological role but enables tracing and quantitation.

  • Essential amino acid: L‑valine is one of the three branched‑chain amino acids (BCAAs), incorporated co‑translationally into proteins via tRNAVal on the ribosome.
  • Metabolic pathways: BCAA catabolism begins with transamination (branched‑chain aminotransferase) to 2‑ketoisovalerate, followed by oxidative decarboxylation via the BCKD complex, yielding isobutyryl‑CoA and ultimately propionyl‑CoA → succinyl‑CoA (anaplerosis into the TCA cycle).
  • Transport: Uptake via system L and other neutral amino acid transporters; competitive interactions with leucine/isoleucine can be probed using 13C5‑valine labeling.
  • Nitrogen metabolism: Participates in nitrogen shuttling through reversible transamination with α‑ketoglutarate ↔ glutamate.
  • Isotope tracing utility: 13C labeling resolves flux through BCAA pathways, reveals exchange with central carbon metabolism (e.g., labeling of citrate, malate via succinyl‑CoA), and quantifies protein synthesis/turnover by MS analysis of valine‑containing peptides.
  • Proteomics: Feeding 13C‑valine can produce characteristic mass shifts in proteomes, aiding peptide identification and positional isotope enrichment studies.

Note: Any biological experimentation must comply with institutional approvals. This product is for research use only (per Product Data). No clinical or therapeutic claims are implied.

Buffer Applications

L‑Valine‑¹³C₅ is not commonly used as a primary buffering agent. As a zwitterionic amino acid, it exhibits limited buffering capacity near its isoelectric point (~pH 6, literature) and broader buffering when combined with conjugate acid/base pairs.

  • Practical use (general):
    • Can serve as a minor component/additive in media to modulate osmolarity or as a defined carbon/nitrogen source in labeling studies, but not as a principal buffer.
    • For pH control in systems containing 13C‑valine, select volatile buffers (ammonium formate/acetate) for LC‑MS workflows or Good’s buffers (HEPES, MOPS) for cell culture; avoid phosphate if downstream MS sensitivity is critical.
  • Recipe hints (if co‑formulated):
    • Prepare 13C‑valine stocks in water; adjust pH with dilute acid/base compatible with the application (e.g., 0.1% formic acid for LC‑MS). Filter sterilize (0.22 µm) for cell culture labeling.

If a dedicated buffer is required, use established buffering systems rather than relying on valine. No item‑specific buffer specifications are provided for this product.

Green Alternatives

While L‑Valine‑¹³C₅ itself is a low‑hazard, nonvolatile solid, sustainable practice focuses on solvent systems and derivatization reagents used alongside it.

  • Greener choices (general):
    • Prefer aqueous or aqueous‑alcoholic systems with volatile buffers (ammonium acetate/formate) for LC‑MS work instead of phosphate buffers that complicate waste streams.
    • For sample cleanup, use solid‑phase extraction (SPE) over large‑volume liquid–liquid extraction with chlorinated solvents.
    • In NMR, D2O is preferable to halogenated deuterated solvents when feasible.
  • Derivatization considerations:
    • If GC‑MS derivatization is required, select lower‑hazard silylation systems where possible and minimize excess reagents; consider LC‑MS methods that avoid derivatization entirely.
  • Energy and waste:
    • Conduct peptide couplings or protection steps (if preparing derivatives) under room‑temperature, high‑efficiency coupling chemistries (e.g., Oxyma/HATU) to reduce energy consumption and side‑product formation.

Comparison (general guidance):

  • Aqueous LC‑MS with volatile salts versus phosphate buffers:
    • Pros: reduced salt waste, better ESI compatibility, easier desalting.
    • Cons: narrower pH buffering range; may require method re‑optimization.
  • D2O versus CDCl3 for NMR:
    • Pros: safer, non‑halogenated, compatible with zwitterionic amino acids.
    • Cons: exchangeable protons broaden/disappear; pD corrections needed.

Note: Isotopic materials entail energy‑intensive production; minimize scale and optimize methods to reduce consumption without compromising data quality.

Pharmaceutical Uses

No therapeutic/clinical use is claimed. Per Product Data, this material is for research use only.

  • Formulation/excipient context (general): While unlabeled amino acids can act as stabilizers, tonicity agents, or bulking agents in parenteral/lyophilized formulations, isotopically labeled L‑valine is typically reserved for analytical and process‑development roles.
  • Analytical/pharmaceutical development applications:
    • Internal standard for bioanalytical LC‑MS assays quantifying valine in pharmacokinetic, metabolism, or stability studies.
    • Tracer in ADME research models to study metabolic pathway engagement (nonclinical).
    • System suitability and instrument performance checks in metabolomics workflows.
  • Regulatory notes: Pharmacopoeial monographs (USP/EP/JP) exist for unlabeled L‑valine; they do not directly apply to the 13C‑labeled isotopologue. Any GMP use would require appropriate qualification of isotopic enrichment, purity, and residuals per internal quality systems.

All uses must remain within nonclinical research and development; for any regulated application, consult QA and regulatory affairs and verify suitability with the product’s CoA and SDS.

Physical Properties
  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet. (Literature/computed for ¹³C5 isotopologue: ~122.11–122.15 g/mol.)
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet. (Literature: ¹³C5H11NO2.)
  • Melting point: Not specified for this item. (Literature for L‑valine: ~315–320 °C, decomposes.)
  • Boiling point: Not applicable (decomposes before boiling; literature for amino acids generally).
  • Density: Not specified for this item.
  • Solubility: Not specified for this item. (General/literature: amino acids like L‑valine are moderately soluble in water; solubility increases in acidic or basic media due to ionization; very low solubility in most nonpolar organic solvents.)
  • pKa (literature, unlabeled L‑valine; 13C does not materially alter acid–base behavior):
    • pKa1 (–CO2H): ~2.3
    • pKa2 (–NH3+): ~9.6–9.8
    • Isoelectric point (pI): ~6.0
  • LogP/logD: Not specified for this item. (General: strongly hydrophilic zwitterion at neutral pH; effective logD << 0.)
  • Optical rotation: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable (solid).

All item‑specific specifications (e.g., enrichment %, residual solvents, inorganic content) should be taken from the CoA/Spec Sheet for this specific lot.

Quality and Grades
  • Grade/purity: Not specified for this item; refer to CoA/Spec Sheet for enrichment level (e.g., % ¹³C at each carbon), chemical purity, and residual solvent/ash specifications.
  • Isotopic enrichment: For stable‑isotope standards, the critical quality attribute is the 13C enrichment at each carbon and the overall isotopomer distribution (e.g., M+5 fraction). Verify on CoA (often by GC/LC‑MS and/or 13C NMR) before quantitative tracer or internal‑standard use.
  • Chemical purity vs isotopic purity: Chemical purity (e.g., HPLC %) indicates the fraction of the desired compound vs chemical impurities; isotopic purity indicates the fraction of the desired isotopologue vs other isotopologues (M+4, M+3, etc.). Both impact quantitation in MS and NMR.
  • Optical purity: For L‑amino acids, enantiomeric excess (ee or enantiomeric ratio) can be critical for biochemical and chiral synthesis applications. Confirm L‑configuration on the CoA (e.g., by chiral HPLC or enzymatic assay).
  • Residual solvent/metals/volatile impurities: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/additives: Not specified for this item; typically not required for crystalline amino acids; confirm absence/presence on CoA if downstream assays are sensitivity‑limited.
  • Documentation: Batch CoA should include analytical method(s), isotopic assay, water content (e.g., KF), and storage recommendations. Request a Spec Sheet for additional test parameters if required by your QA.
Reaction and Applications

Primary applications of L‑Valine‑¹³C₅ center on stable‑isotope tracing and quantitative analytics.

  • Stable‑isotope tracer studies (general):
    • Metabolic flux analysis (MFA) of branched‑chain amino acid (BCAA) pathways; track incorporation of 13C into downstream metabolites (e.g., 2‑ketoisovalerate, propionyl‑CoA, TCA cycle intermediates).
    • Protein turnover studies: pulse/trace incorporation into proteins, analyze peptide isotopologue envelopes by LC‑MS/MS.
    • In vivo/in vitro uptake kinetics: monitor transport and transamination by 13C labeling patterns.
  • Internal standards (general):
    • LC‑MS quantitation of valine in biofluids (plasma, CSF, urine) using 13C5‑valine as an internal standard to correct matrix effects and ionization variability.
    • GC‑MS workflows after derivatization (e.g., TBDMS, MTBSTFA, or ethoxycarbonyl/ethyl ester): match retention/ionization with mass offset of +5.
  • NMR applications (general):
    • 13C NMR sensitivity enhancement; assignment of valine carbons in complex matrices.
    • Protein NMR labeling (cell‑free or microbial expression with labeled amino acid feeds) to enhance 13C signals at valine residues.
  • Synthetic/biocatalytic uses (general):
    • As a chiral building block, 13C labeling enables positional isotope effects studies and mechanistic probes in enzyme catalysis (aminotransferases, dehydrogenases).

Practical tips:

  • For MS quantitation, match the chemical form (free acid vs salt) of standard and analyte where possible; correct for natural abundance.
  • Confirm isotopic enrichment and absence of unlabeled valine contamination to minimize cross‑talk in MRM transitions.
  • Prepare fresh working solutions to avoid microbial growth; sterile‑filter if used in cell culture labeling.
Reaction Conditions

General guidance for common transformations of L‑valine derivatives (literature; adapt for 13C‑labeled material to preserve isotopic integrity):

  • N‑Protection (Boc/Fmoc/Cbz):
    • Solvent: aqueous dioxane or DMF; base: NaHCO3/Na2CO3 (Boc2O) or NaHCO3 with Fmoc‑OSu; 0–25 °C, 1–4 h for Boc/Fmoc. Cbz‑Cl with Na2CO3 at 0–5 °C then RT.
    • Notes: keep pH 8–9 to minimize racemization; monitor by TLC/HPLC.
  • Coupling to form amide/peptide bonds:
    • Reagents: HATU/HBTU/EDC·HCl + Oxyma/HOAt; base: DIPEA; solvent: DMF/NMP; 0–25 °C, 0.5–4 h. Typical literature yields: 70–95% depending on partner and protection.
    • Tips: pre‑activate carboxylate briefly; avoid prolonged base exposure.
  • Esterification (Fischer or Steglich):
    • Steglich: DCC (or DIC) + DMAP in dry CH2Cl2/DMF; 0–25 °C, 2–12 h; good to excellent yields.
    • Benzyl ester: EDC/DMAP or BnBr under phase‑transfer for protected amine; Cbz/Bn removable by hydrogenolysis (H2, Pd/C, RT–40 °C).
  • Deprotection:
    • Boc: TFA in CH2Cl2 (1:1 to neat) at 0–25 °C, 0.5–2 h.
    • Fmoc: 20% piperidine in DMF, RT, 10–30 min (monitor to avoid side reactions).
    • Cbz/Bn: H2 (1–3 atm), Pd/C (5–10 wt%), MeOH/EtOH/EtOAc, RT–40 °C.
  • Derivatization for GC‑MS:
    • MTBSTFA or TBDMS‑Cl with imidazole in acetonitrile/pyridine; 60–80 °C, 30–60 min; dry conditions critical.

For isotope‑tracer applications, avoid high‑temperature acidic/basic conditions that may cause isotope scrambling or decarboxylation. Always verify isotopic integrity by LC‑MS or 13C NMR post‑transformation.

Safety and Handling
  • GHS classification, signal word, pictograms, H‑statements: Not specified for this item; consult the SDS for authoritative hazard information.
  • General safety profile (amino acids, literature/general): typically low acute toxicity and not classified as hazardous under many jurisdictions; nevertheless, handle as a laboratory chemical.
  • Likely hazards: dust may cause mechanical irritation to eyes/respiratory tract; ingestion in laboratory context is prohibited; no known flammability concerns typical of crystalline amino acids.
  • Personal protective equipment (PPE): laboratory coat, safety glasses, and appropriate gloves (e.g., nitrile). Use dust control (local exhaust) if handling powders on scale.
  • Handling: avoid creating dust; use clean, dry tools to prevent moisture uptake and caking. For analytical work (MS/NMR), minimize atmospheric CO2/H2O exposure to avoid pH drift and adventitious carbonate.
  • Incompatibilities (general): strong oxidizers; strong acids/bases may cause decomposition on heating; avoid mixing with nitrosating agents (amines can form nitrosamines under harsh conditions).
  • First aid (overview; defer to SDS):
    • Inhalation: move to fresh air; seek medical advice if symptoms persist.
    • Skin/eyes: rinse with water; remove contaminated clothing; seek medical attention if irritation continues.
    • Ingestion: rinse mouth; do not induce vomiting; obtain medical attention.
  • Fire fighting (general): nonflammable solid; if involved in fire, use water spray, CO2, foam, or dry chemical as appropriate to surroundings; thermal decomposition may release nitrogen oxides and COx.
  • Waste disposal: collect aqueous solutions and solids for disposal according to institutional and local regulations; do not discharge to drains without authorization.
Solvent Selection

L‑Valine‑¹³C₅ is a zwitterionic, hydrophilic solid; solvent choice is governed by acid–base state and target application (MS, NMR, synthesis).

  • Polarity/miscibility (general):
    • Water: good solubility; highest near acidic (≤pH ~2) or basic (≥pH ~10) conditions due to full ionization.
    • Alcohols (MeOH, EtOH): limited to moderate solubility; can aid in sample preparation for LC‑MS when mixed with water and a volatile modifier (e.g., 0.1% formic acid or 5–10 mM ammonium formate).
    • Polar aprotics (DMF/DMSO): high solubility; useful for stock solutions, derivatization, or peptide‑coupling contexts.
    • Nonpolar solvents (EtOAc, hexane, toluene): effectively insoluble.
  • pH strategy (general): Dissolve in minimal water; adjust pH with volatile acids/bases (formic acid, acetic acid, ammonium hydroxide) for LC‑MS compatibility. Avoid strong inorganic salts if samples will be ESI‑MS analyzed.
  • NMR sample prep: 13C/1H NMR in D2O (adjust pD with DCl/NaOD) or in DMSO‑d6. For quantitative 13C NMR, use relaxation agent (e.g., Cr(acac)3) and calibrated pulse delays.
  • When to choose alternatives: For less hydrophilic media or peptide coupling in organic solvents, use protected derivatives (e.g., Fmoc‑Val‑OH) that dissolve better in DMF/DMF–DCM mixtures.
  • Volatility considerations: Aqueous/aqueous‑organic mobile phases with volatile buffers (ammonium formate/acetate) are preferred for LC‑MS tracer studies to preserve isotopologue integrity.
Storage and Reconstitution
  • Storage (item‑specific): Room temperature (per Product Data). For best stability of analytical standards, many users store working solids and solutions at reduced temperature.
  • Recommended practice (general):
    • Solid: keep tightly closed in a clean, dry container; protect from moisture and prolonged light; use desiccant if ambient humidity is high.
    • Solutions: prepare in high‑purity water or appropriate aqueous/aqueous‑organic media. For long‑term storage of solutions, aliquot and store at 2–8 °C (short term) or ≤−20 °C (long term) to limit microbial growth and degradation; avoid repeated freeze–thaw cycles.
  • Reconstitution (general):
    • Water or buffer: dissolve to the desired concentration; adjust pH with volatile acid/base if LC‑MS is planned. Gentle warming and vortexing can aid dissolution. Filter sterilize (0.22 µm) for cell culture or long‑term storage.
    • NMR: dissolve in D2O or DMSO‑d6; add internal reference if required for quantitation.
  • Stability considerations: amino acids are generally stable in the solid state; in solution, minimize exposure to elevated temperature and extreme pH to avoid racemization or degradation. Verify isotopic integrity after extended storage by LC‑MS or 13C NMR.
  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.

Always consult the product’s SDS for handling and storage precautions appropriate to your laboratory environment.

Structure and Identity

L‑Valine‑¹³C₅ is the uniformly 13C‑labeled isotopologue of the essential branched‑chain amino acid L‑valine, used as a stable‑isotope tracer and MS/NMR internal standard.

  • Item-specific identifiers from Product Data:
    • CAS: 55443-52-2
    • InChIKey: Not specified for this item; refer to CoA/Spec Sheet.
    • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Isotopic composition (literature/general): uniformly 13C‑enriched at all five carbon positions of L‑valine (commonly denoted U‑13C5‑L‑valine).
  • Molecular formula (literature/general for the isotopologue): ¹³C5H11NO2.
  • Molecular weight (computed/literature, isotopologue): ~122.11–122.15 g/mol (unlabeled L‑valine is 117.15 g/mol; +5 × 1.00335 for 13C enrichment).
  • Structural features (general):
    • Alpha‑amino acid backbone with an α‑amino (–NH2/–NH3+) and α‑carboxyl (–CO2H/–CO2–) group at Cα.
    • Branched isopropyl side chain (valyl) at the β‑carbon, making it a branched‑chain amino acid (BCAA).
    • One stereogenic center at Cα with L‑configuration (S absolute configuration by Cahn–Ingold–Prelog for L‑valine).
  • 2D description in words (general): a central chiral carbon bearing an amino group, a carboxyl group, a hydrogen, and an isopropyl substituent; in aqueous media near neutral pH it exists predominantly as a zwitterion (–NH3+ … –O2C–).

Note: Exact isotopomer distribution, enrichment %, and any salt form should be confirmed on the item’s CoA/Spec Sheet.

Synthetic Utility

From a synthetic chemistry perspective, L‑Valine‑¹³C₅ serves as both a chiral pool starting material and an isotopic probe.

  • Chiral building block (general):
    • Conversion to N‑protected derivatives (Fmoc‑Val‑OH, Boc‑Val‑OH, Cbz‑Val‑OH) enables peptide synthesis (SPPS and solution‑phase). The 13C label is preserved through typical protection/coupling/deprotection sequences.
    • Esterification of the carboxyl group (e.g., methyl/benzyl esters) facilitates coupling or kinetic studies; hydrogenolysis removes Cbz/benzyl groups under mild conditions.
  • Mechanistic/isotope‑effect studies:
    • Uniform 13C labeling allows site‑specific 13C NMR observation and quantitation in enzyme mechanisms (aminotransferases, dehydrogenases) and decarboxylation steps (monitor CO2/ bicarbonate 13C release).
    • Enables isotopologue‑resolved kinetics and mass balance in multistep syntheses involving valine‑derived auxiliaries or intermediates.
  • Derivatization for analytics:
    • GC‑MS: convert to volatile derivatives (e.g., tert‑butyldimethylsilyl, ethoxycarbonyl/ethyl ester) maintaining a +5 m/z offset vs unlabeled analyte.
    • LC‑MS: dansylation/AccQ‑Tag type reagents can enhance ionization and chromatographic behavior when needed.

Practical notes:

  • Protect the amine prior to acylation to avoid mixtures; use coupling agents (HATU/HBTU/DIC+Oxyma) in DMF or NMP with DIPEA.
  • Maintain stereochemistry: avoid racemization by using mild bases, low temperatures, and racemization‑suppressing additives during coupling.
Target Specificity

Not applicable. This product is a small‑molecule amino acid (stable‑isotope labeled) and is not an antibody or affinity reagent. No target/epitope, species reactivity, clone, or isotype information applies.

Frequently Asked Questions

What is the purity of this product?
This product is isotopically enriched to ≥99 atom% carbon-13. Isotopic enrichment is a separate specification from chemical purity — a labelled compound has both. This product is supplied at ≥97% purity (chemical assay). Lot-specific values are stated on the Certificate of Analysis.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 55443-52-2, and the molecular weight is 122.11 g/mol. InChIKey KZSNJWFQEVHDMF-JRGPAWSWSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.